Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,190 | 260,843 | 173,959 | 281,080 | 306,744 |
| Marketable Securities | 1,303,648 | 1,476,335 | 1,387,000 | 1,430,240 | 1,354,683 |
| TOTAL | $1,552,668 | $1,813,488 | $1,627,361 | $1,767,167 | $1,715,775 |
| Non-Current Assets | |||||
| PPE Net | 260,390 | 260,695 | 257,370 | 253,486 | 242,266 |
| Investments And Advances | 1,020,896 | 1,004,017 | 881,664 | 959,256 | 1,165,091 |
| Other Non-Current Assets | 304,200 | 270,108 | 236,322 | 191,691 | 182,231 |
| TOTAL | $1,585,486 | $1,534,820 | $1,375,356 | $1,404,433 | $1,589,588 |
| Total Assets | $3,138,154 | $3,348,308 | $3,002,717 | $3,171,600 | $3,305,363 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 100,919 | 63,060 | 70,904 | 48,962 | 31,414 |
| Accrued Expenses | 24,728 | 30,247 | 31,068 | 24,592 | 32,214 |
| TOTAL | $271,277 | $242,082 | $205,750 | $200,046 | $154,486 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 108,935 | 110,212 | 111,457 | 78,672 | 79,543 |
| TOTAL | $108,935 | $110,212 | $111,457 | $78,672 | $79,543 |
| Total Liabilities | $380,212 | $352,294 | $317,207 | $278,718 | $234,029 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 148,805 | 144,398 | 143,920 | 130,906 | 129,823 |
| Common Shares | 148 | 147 | 134 | 133 | 133 |
| Retained earnings | -2,759,871 | -2,475,569 | -2,154,947 | -1,908,440 | -1,695,610 |
| Other shareholders' equity | -7,546 | -6,834 | 1,587 | 856 | -1,887 |
| TOTAL | $2,757,942 | $2,996,014 | $2,685,510 | $2,892,882 | $3,071,334 |
| Total Liabilities And Equity | $3,138,154 | $3,348,308 | $3,002,717 | $3,171,600 | $3,305,363 |